Cancer Research

Ivan Kairatov is a seasoned expert in biopharmaceutical research and development, possessing a profound understanding of the technological shifts currently reshaping oncology. With a career dedicated to navigating the complexities of drug innovation, he has a unique perspective on how precision

The clinical landscape of modern oncology is undergoing a profound transformation as biotechnology firms successfully engineer specialized immune cells to target and eliminate aggressive blood cancers that have developed a resistance to conventional medical interventions. Imugene Limited, a

Modern oncology is currently witnessing a paradigm shift where the brute force of systemic chemotherapy is being replaced by sophisticated molecular delivery systems designed to spare healthy tissue. While traditional treatments often ravage the entire body to reach a localized tumor, the

The persistent challenge of treating glioblastoma multiforme has long remained one of the most formidable frontiers in modern oncology due to the aggressive nature of these tumors and the restrictive blood-brain barrier. For decades, the standard of care has relied heavily on surgical resection

While modern medicine has traditionally viewed oncology through the narrow lens of localized tumor growth, a paradigm shift is occurring as researchers recognize cancer as a systemic "metabolic thief" that reengineers the body's entire chemical landscape to fuel its survival. This biological

A groundbreaking cross-sectional study at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán has unveiled critical genetic insights that could redefine the standard of care for Mexican men diagnosed with stage IV prostate cancer. Historically, the genomic landscape of prostate